← Open Payments lookup

SEUNG LEE: Open Payments

NPI 1770693996 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,636 in 101 payments from 16 companies in 2025. Trend: 2023 $1,998 · 2024 $2,257 · 2025 $1,636

Food & beverage: $1,636
CompanyPaymentsAmount
ABBVIE INC.22$355
Otsuka America Pharmaceutical, Inc.20$280
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$235
Takeda Pharmaceuticals U.S.A., Inc.7$128
Neos Therapeutics, LP8$126
Vanda Pharmaceuticals Inc.7$123
Neurocrine BioSciences, Inc.7$119
Teva Pharmaceuticals USA, Inc.3$54
E.R. Squibb & Sons, L.L.C.3$48
Alkermes, Inc.2$39

Products named: VRAYLAR, CAPLYTA, REXULTI, TRINTELLIX, INGREZZA, HETLIOZ, ABILIFY MAINTENA, Adzenys XR-ODT.

Industry payments across NJ — which companies pay providers there.